| Systematic approach to developing splice modulating antisense oligonucleotides MT Aung-Htut, CS McIntosh, KA Ham, IL Pitout, LL Flynn, K Greer, ... International journal of molecular sciences 20 (20), 5030, 2019 | 21 | 2019 |
| In vitro validation of phosphorodiamidate morpholino oligomers MT Aung-Htut, CS McIntosh, KA West, S Fletcher, SD Wilton Molecules 24 (16), 2922, 2019 | 21 | 2019 |
| Evidence that the LRRK2 ROC domain Parkinson's disease‐associated mutants A1442P and R1441C exhibit increased intracellular degradation ID Greene, F Mastaglia, BP Meloni, KA West, J Chieng, CJ Mitchell, ... Journal of Neuroscience Research 92 (4), 506-516, 2014 | 21 | 2014 |
| Nonsequential Splicing Events Alter Antisense-Mediated Exon Skipping Outcome in COL7A1 KA Ham, MT Aung-Htut, S Fletcher, SD Wilton International Journal of Molecular Sciences 21 (20), 7705, 2020 | 16 | 2020 |
| A splice intervention therapy for autosomal recessive juvenile Parkinson’s disease arising from Parkin mutations D Li, MT Aung-Htut, KA Ham, S Fletcher, SD Wilton International Journal of Molecular Sciences 21 (19), 7282, 2020 | 16 | 2020 |
| Splice modulating antisense oligonucleotides restore some acid-alpha-glucosidase activity in cells derived from patients with late-onset Pompe disease MT Aung-Htut, KA Ham, M Tchan, R Johnsen, FJ Schnell, S Fletcher, ... Scientific Reports 10 (1), 6702, 2020 | 16 | 2020 |
| Induction of cryptic pre-mRNA splice-switching by antisense oligonucleotides KA Ham, NP Keegan, CS McIntosh, MT Aung-Htut, K Zaw, K Greer, ... Scientific Reports 11 (1), 15137, 2021 | 8 | 2021 |
| Novel mutations found in individuals with adult-onset Pompe disease MT Aung-Htut, KA Ham, MC Tchan, S Fletcher, SD Wilton Genes 11 (2), 135, 2020 | 7 | 2020 |
| Cryptic U2-dependent pre-mRNASplice site usage induced by splice switching antisense oligonucleotides K Ham, N Keegan, C McIntosh, M Aung-Htut, K Zaw, K Greer, S Fletcher, ... Research Square Preprints, 2021 | 1 | 2021 |
| CYPA and CD147 expression analysis in human glioblastoma: Evidence for a correlation with reduced survival V Matthews, P Candy, KA West, N Knuckey, P Robbins, Jeffcote, S Boulos Journal of Translational Science 4 (5), 1-7, 2018 | 1 | 2018 |
| Induced alternative splicing an opportunity to study PCSK9 protein isoforms at physiologically relevant concentrations JM Cale, KA Ham, D Li, CS McIntosh, GF Watts, SD Wilton, MT Aung-Htut Scientific reports 13 (1), 19725, 2023 | | 2023 |
| Developing Therapeutic Splice-Correcting Antisense Oligomers for Adult-Onset Pompe Disease with c.-32-13T> G Mutation KA Ham, RD Johnsen, M Tchan, SD Wilton, MT Aung-Htut Muscular Dystrophy Therapeutics: Methods and Protocols, 239-251, 2022 | | 2022 |
| Nonsequential Pre-mRNA Splicing: From basic understanding to impacts on Splice-Manipulating therapies KA Ham, SD Wilton, MT Aung-Htut Messenger RNA Therapeutics, 429-446, 2022 | | 2022 |
| Glycogen Storage Disease Type II MT Aung-Htut, KA Ham, M Tchan, R Johnsen, FJ Schnell, S Fletcher, ... | | 2020 |
| Small chemical modulation of induced alternative splicing D Li, K Greer, K West, A Addams, S Fletcher, S Wilton Journal of Gene Medicine 20 (1), 2018 | | 2018 |
| Late onset Pompe disease: Rescue of acid alpha-glucosidase expression by splice modification MT Aung-Htut, K West, L Barrett, K Cardwell, FJ Schnell, S Fletcher, ... Journal of Gene Medicine 20 (1), 2018 | | 2018 |
| Antisense oligonucleotide treatment of COL7A1 causes non-specific splice modifications KA West, S Fletcher The journal of gene medicine 20 (1), 32, 2018 | | 2018 |
| Comparison of three different mutations in DMD exon 40 that influence the efficiency of AO induced exon skipping KA West, L Barrett, S Fletcher, SD Wilton The Journal of Gene Medicine 17 (8-9), 2015 | | 2015 |
